Advertisement

Another Chinese vax gets nod for emergency use in Pak

Follow The Hawk on Google News+ Follow

Advertisement


Islamabad: It will become the fourth vaccine to be allowed for emergency use in Pakistan, the Dawn news reported.

Cansino Biologics Inc is the only company that has conducted clinical trial in Pakistan, with around 18,000 volunteers participating from across the country.

Advertisement

The analysis, which was released by the Independent Data Monitoring Committee (IDMC), showed that it had 74.48 per cent efficacy rate in preventing symptomatic cases and 100 per cent in preventing severe disease.

Also readFSSAI to initiate action against Bisleri over unsafe water sample

The authorisation for emergency use has been issued on Friday just a day after Mexico decided to use Cansino Bio's vaccine to immunise its citizens.

In another development, Drap's Clinical Trial Committee allowed another company to hold clinical trial in Pakistan.

Advertisement

During the trial, around 9,000 volunteers will be vaccinated through the University of Health Sciences (UHS) and Aga Khan University (AKU).

Last month, Cansino Bio completed its clinical trial in five countries -- Pakistan, Mexico, Argentina, Chile and Russia -- and sent the data to the IDMC to officially announce the efficacy rate.

—IANS

Get The Hawk first on Google

Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.

Share this story

Advertisement

India eyes space-based drug development as scientists, startups explore microgravity researchRead next →India eyes space-based drug development as scientists, startups explore microgravity researchHealth · 22 Nov 2026, 03:08 PM IST